Stefan Knackmuss Selected Research

Laminin Receptors

1/2015	Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity.
1/2014	Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
1/2013	Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18.
1/2013	In vitro inhibition of angiogenesis by antibodies directed against the 37kDa/67kDa laminin receptor.
5/2012	Anti-LRP/LR-specific antibody IgG1-iS18 significantly reduces adhesion and invasion of metastatic lung, cervix, colon and prostate cancer cells.
8/2008	Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy.
5/2008	Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor.
1/2008	Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Knackmuss Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 05/2008
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2015 - 05/2008
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 08/2008 - 01/2008
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Glioma (Gliomas) 01/2017
1	Amyloid Plaque 01/2016
1	Body Weight (Weight, Body) 06/2015
1	Hodgkin Disease (Hodgkin's Disease) 06/2015
1	Liver Neoplasms (Liver Cancer) 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 05/2012
1	Lung Neoplasms (Lung Cancer) 05/2012
1	Colonic Neoplasms (Colon Cancer) 05/2012
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2012
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2008
1	Scrapie 08/2008
1	Nervous System Diseases (Neurological Disorders) 01/2008
1	Asthma (Bronchial Asthma) 03/2007

Drug/Important Bio-Agent (IBA)

8	Laminin ReceptorsIBA 01/2015 - 01/2008
5	AntibodiesIBA 01/2017 - 01/2008
3	laminin 1IBA 01/2014 - 05/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2017
2	PrionsIBA 08/2008 - 05/2008
2	Single-Chain AntibodiesIBA 08/2008 - 01/2008
1	Phosphates (Orthophosphate)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	EnzymesIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Immunoglobulin Fc FragmentsIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	epidermal growth factor receptor VIIIIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	AFM13IBA 06/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015
1	matrigelIBA 01/2014
1	Amyloid beta-PeptidesIBA 01/2013
1	Peptides (Polypeptides)IBA 10/2008
1	Radioisotopes (Radionuclides)IBA 10/2008
1	Polysaccharides (Glycans)IBA 05/2008
1	Indicators and Reagents (Reagents)IBA 05/2008
1	Messenger RNA (mRNA)IBA 05/2008
1	Laminin (Merosin)IBA 05/2008
1	Prion ProteinsIBA 01/2008
1	CytokinesIBA 03/2007
1	Interleukin-13IBA 03/2007

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2008
2	Immunotherapy 01/2017 - 06/2015